AUG 29, 2016 10:11 AM PDT

Harnessing Dangerous Parasites to Fight Cancer

WRITTEN BY: Carmen Leitch

OOPS! THAT EXPERIMENT FAILED...

It's not your fault! Something went wrong with our formula.
Please begin your experiment again by clicking here.

If this error continues to occur please contact us at support@labroots.com.

The relationship between parasites and cancer is not new; researchers have known for many years about parasites that can cause cancers. But what about using parasites to fight cancer? A research group led by David Bzik of the Geisel School of Medicine at Dartmouth is seeking to learn more about how a pathogenic parasite called Toxoplasma gondii can help patients battle cancerous tumors.
 

T. gondii is a common parasite many people know about because it is carried by cats. If you’d like to get a deep understanding of it, check out the video above.

Ideally, the native immune system of a patient could be used against cancer, but because of immune tolerance, the body is unable to identify what cells should be slated for destruction. The immune system has to be able to distinguish between harmless, native cells, and foreign invaders. Scientists attempted to develop vaccines for cancer but because there was not a good understanding of the immune system, the approaches failed.

Bzik’s research team surmised that T.gondii would be great for use in cancer treatment because of how it manipulates the immune system. After infection, both parasite and host must be able to survive. The parasite secretes proteins that control the immune response of the host, and that allows the parasite to survive.  That power over the immune system suggested that it could be harnessed to turn the body against invasive tumors that the body’s immune system would not otherwise recognize.

Building on previous work, the investigators created a strain of T.gondii suitable for use in a vaccine – it had been genetically modified so it wasn’t able to reproduce inside of the host. They found that when the vaccine (called cps) was injected into mice that had deadly types of ovarian cancer, the mice were cured of solid tumors. A pretty informative and short video explaining that work is seen below.
 

"Cps stimulates amazingly effective immunotherapy against cancers, superior to anything seen before," explained Bzik. "The ability of cps to communicate in different and unique ways with the cancer and special cells of the immune system breaks the control that cancer has leveraged over the immune system."

This research team has been at work for years to understand the details behind how T.gondii impacts the immune system. Publishing in PLOS Genetics, they recently identified what proteins the parasite secretes that elicit the immune response to its invasion. Importantly, these proteins work to modulate the response of the immune system to infection.

After deleting each gene required for the secretion of those proteins, mice with aggressive cancers were injected with the genetically altered parasites. The scientists found that T. gondii secretes certain rhoptry and dense granule effector proteins before and after the invasion of a host cell. Those proteins worked to both control the effectiveness of the antitumor response by the host, as well as increase the survival of mice with ovarian tumors.

Other research groups are at work developing similar cancer therapies. Enlistment of the bacterium Listeria monocytogenes (attenuated for use in vaccines) in the fight against pancreatic tumors is currently in clinical trials. And since 2010, sipuleucel-T (Provenge®) has been used in patients with metastatic prostate cancer. Studies show that Provenge reduced the risk of death by 22.5% in patients.

The National Cancer Institute has prepared information on cancer vaccines if you’d like to learn more about how cancer vaccines work and what research is under way.
 
Sources: Cancer Research, NIH National Cancer Institute, Provenge, PLOS Genetics, Science Daily via Norris Cotton Cancer Center Dartmouth-Hitchcock Medical Center, Infection and Immunity, AAAS/Eurekalert! via PLOS
 
About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
MAY 08, 2018
Genetics & Genomics
MAY 08, 2018
A Genetic Assessment of a Drug-resistant Pathogen
Drug resistance is a growing threat to public health and is responsible for the death of around 23,000 people every year in the US alone....
JUN 14, 2018
Microbiology
JUN 14, 2018
The Rise of Carbapenem Resistance
European scientists are warning clinicians about a dangerous group of microbes that resist the effects of drugs used as a last resort....
JUN 21, 2018
Clinical & Molecular DX
JUN 21, 2018
Unique Gene Signature in the Blood Indicates TB Diagnosis
A unique series of genes could tell doctors that a person will develop a tuberculosis (TB) infection months before symptoms are visible. From The Francis C...
JUN 25, 2018
Microbiology
JUN 25, 2018
Gut Microbes Linked to Development of Liver Disease
The bacteria that live in our gut release compounds that might act as biomarkers, and may be a part of disease development....
JUN 29, 2018
Microbiology
JUN 29, 2018
Finding a Way to End a Persistent Cholera Epidemic
Tracing back to Indonesia, 1961, the current outbreak has been going on for over fifty years....
AUG 03, 2018
Microbiology
AUG 03, 2018
Dog Lick Leads to Limb Amputation
The CDC says don't give your dog up; this is thought to be a very rare case....
Loading Comments...